100 related articles for article (PubMed ID: 10601851)
1. The prothrombin gene is expressed in the rat kidney: Implications for urolithiasis research.
Grover PK; Dogra SC; Davidson BP; Stapleton AM; Ryall RL
Eur J Biochem; 2000 Jan; 267(1):61-7. PubMed ID: 10601851
[TBL] [Abstract][Full Text] [Related]
2. Prothrombin gene expression in rat kidneys provides an opportunity to examine its role in urinary stone pathogenesis.
Grover PK; Stapleton AM; Ryall RL
J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S404-7. PubMed ID: 10541273
[TBL] [Abstract][Full Text] [Related]
3. Gene expression of prothrombin in the human kidney and its potential relevance to kidney stone disease.
Stapleton AM; Timme TL; Ryall RL
Br J Urol; 1998 May; 81(5):666-71; discussion 671-2. PubMed ID: 9634038
[TBL] [Abstract][Full Text] [Related]
4. Further evidence linking urolithiasis and blood coagulation: urinary prothrombin fragment 1 is present in stone matrix.
Stapleton AM; Dawson CJ; Grover PK; Hohmann A; Comacchio R; Boswarva V; Tang Y; Ryall RL
Kidney Int; 1996 Mar; 49(3):880-8. PubMed ID: 8648933
[TBL] [Abstract][Full Text] [Related]
5. The hole truth: intracrystalline proteins and calcium oxalate kidney stones.
Ryall RL; Fleming DE; Grover PK; Chauvet M; Dean CJ; Marshall VR
Mol Urol; 2000; 4(4):391-402. PubMed ID: 11156707
[TBL] [Abstract][Full Text] [Related]
6. Renal prothrombin mRNA is significantly decreased in a hyperoxaluric rat model of nephrolithiasis.
Grover PK; Miyazawa K; Coleman M; Stahl J; Ryall RL
J Pathol; 2006 Nov; 210(3):273-81. PubMed ID: 16981243
[TBL] [Abstract][Full Text] [Related]
7. Effects of oxalate exposure on Madin-Darby canine kidney cells in culture: renal prothrombin fragment-1 mRNA expression.
Moryama MT; Domiki C; Miyazawa K; Tanaka T; Suzuki K
Urol Res; 2005 Dec; 33(6):470-5. PubMed ID: 16320015
[TBL] [Abstract][Full Text] [Related]
8. Gene expression of prothrombin in human and rat kidneys: basic and clinical approach.
Suzuki K; Tanaka T; Miyazawa K; Nakajima C; Moriyama M; Suga K; Murai M; Yano J
J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S408-11. PubMed ID: 10541274
[TBL] [Abstract][Full Text] [Related]
9. The effect of warfarin therapy on the charge properties of urinary prothrombin fragment 1 and crystallization of calcium oxalate in undiluted human urine.
Buchholz NP; Kim DS; Grover PK; Dawson CJ; Ryall RL
J Bone Miner Res; 1999 Jun; 14(6):1003-12. PubMed ID: 10352110
[TBL] [Abstract][Full Text] [Related]
10. Renal prothrombin: quantification of mRNA using reverse transcription-polymerase chain reaction in a rat model.
Grover PK; Miyazawa K; Ryall RL
Electrophoresis; 2004 Mar; 25(6):797-803. PubMed ID: 15004838
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of calcium oxalate crystal growth and aggregation by prothrombin and its fragments in vitro: relationship between protein structure and inhibitory activity.
Grover PK; Ryall RL
Eur J Biochem; 1999 Jul; 263(1):50-6. PubMed ID: 10429186
[TBL] [Abstract][Full Text] [Related]
12. Effects of urinary prothrombin fragment 1 in the formation of calcium oxalate calculus.
Liu J; Chen J; Wang T; Wang S; Ye Z
J Urol; 2005 Jan; 173(1):113-6. PubMed ID: 15592049
[TBL] [Abstract][Full Text] [Related]
13. Effect of prothrombin and its activation fragments on calcium oxalate crystal growth and aggregation in undiluted human urine in vitro: relationship between protein structure and inhibitory activity.
Grover PK; Ryall RL
Clin Sci (Lond); 2002 Apr; 102(4):425-34. PubMed ID: 11914105
[TBL] [Abstract][Full Text] [Related]
14. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
Ryall RL; Chauvet MC; Grover PK
BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
[TBL] [Abstract][Full Text] [Related]
15. Blood coagulation proteins and urolithiasis are linked: crystal matrix protein is the F1 activation peptide of human prothrombin.
Stapleton AM; Ryall RL
Br J Urol; 1995 Jun; 75(6):712-9. PubMed ID: 7613825
[TBL] [Abstract][Full Text] [Related]
16. A study of crystal matrix extract and urinary prothrombin fragment 1 from a stone-prone and stone-free population.
Durrbaum D; Rodgers AL; Sturrock ED
Urol Res; 2001 Apr; 29(2):83-8. PubMed ID: 11396733
[TBL] [Abstract][Full Text] [Related]
17. Expression of heparan sulfate proteoglycan mRNA in rat kidneys during calcium oxalate nephrolithiasis.
Iida S; Miyajima J; Suzuki K; Matsuoka K; Inoue M; Noda S
Urol Res; 1997; 25(5):361-4. PubMed ID: 9373918
[TBL] [Abstract][Full Text] [Related]
18. [The effects of the active constituents of Alisma orientalis on renal stone formation and bikunin expression in rat urolithiasis model].
Cao ZG; Liu JH; Zhou SW; Wu W; Yin CP; Wu JZ
Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1276-9. PubMed ID: 15387965
[TBL] [Abstract][Full Text] [Related]
19. Association between human prothrombin variant (T165M) and kidney stone disease.
Rungroj N; Sudtachat N; Nettuwakul C; Sawasdee N; Praditsap O; Jungtrakoon P; Sritippayawan S; Chuawattana D; Borvornpadungkitti S; Predanon C; Susaengrat W; Yenchitsomanus PT
PLoS One; 2012; 7(9):e45533. PubMed ID: 23029076
[TBL] [Abstract][Full Text] [Related]
20. Synergism between urinary prothrombin fragment 1 and urine: a comparison of inhibitory activities in stone-prone and stone-free population groups.
Webber D; Rodgers AL; Sturrock ED
Clin Chem Lab Med; 2002 Sep; 40(9):930-6. PubMed ID: 12435111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
